Here are three notes on the coverage expansion.
1. In 2011, CMS said MRIs for Medicare beneficiaries with cardiac devices could only be covered in “evidence development” cases, or clinical trials.
2. Medicare will now cover an MRI when used according to labeling from the Food and Drug Administration in an MRI environment suitable for patients with cardiac devices. Patients with cardiac devices lacking FDA labeling for use in an MRI environment will only be covered under certain conditions.
3. The decision affects beneficiaries with an implantable cardioverter defibrillator, cardiac resynchronization therapy pacemaker, or cardiac resynchronization therapy defibrillator device.
For the full decision memo, click here.
More articles on healthcare finance:
Georgia hospital closure will result in 200 layoffs
5 latest hospital bankruptcies, closures
A Florida man got 2 CT scans, one in an outpatient facility and another in an ED. The latter cost 33 times more
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
